DIPLOMAT PHARMACY, INC. — Operating Income by Fiscal Year
7 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/d561ccc8-cc88-4260-ad3e-f670e69f05d0/serie/operating-income
| Fiscal year | Operating Income | Period | Evidence |
|---|---|---|---|
| FY 2018 | $-267.3M | 2018-01-01 – 2018-12-31 | evidence 0001104659-19-015644 |
| FY 2017 | $18.6M | 2017-01-01 – 2017-12-31 | evidence 0001104659-18-014114 |
| FY 2016 | $47.1M | 2016-01-01 – 2016-12-31 | evidence 0001104659-17-015229 |
| FY 2015 | $45.9M | 2015-01-01 – 2015-12-31 | evidence 0001104659-16-101031 |
| FY 2014 | $12.6M | 2014-01-01 – 2014-12-31 | evidence 0001047469-15-001589 |
| FY 2013 | $11.1M | 2013-01-01 – 2013-12-31 | evidence 0001047469-15-001589 |
| FY 2012 | $4.9M | 2012-01-01 – 2012-12-31 | evidence 0001047469-15-001589 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).